Frequently Asked Questions
The market is segmented based on , By Drug Class (Vitamin K Antagonist (Warfarin), Non-VKA Oral Anticoagulants (NOACS), Heparin and LMWH, Thrombin Inhibitors (Dabigatran)), Therapeutic Areas (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation, Heart Attack, Stroke, Unstable Angina, Hip Or Knee Replacement Surgery, Others), Route Of Administration (Oral, Parenteral), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
.
The Global Anticoagulant Market size was valued at USD 60.90 USD Million in 2022.
The Global Anticoagulant Market is projected to grow at a CAGR of 5.6% during the forecast period of 2023 to 2030.
The market report covers data from the Brazil, Argentina and Rest of South America as part of South America.
